Director, Commercial Strategy and Business Development Assessment

Job Description

The Director, Commercial Strategy & Business Development Assessment is responsible for supporting U.S. commercial assessments, commercialization planning, strategic evaluations, policy assessments, and integration planning activities for external business development opportunities and internal portfolio expansion initiatives. This role serves as a key commercial assessment partner for evaluating acquisition, licensing, partnership, and portfolio investment opportunities by assessing market attractiveness, patient opportunity, pricing potential, reimbursement feasibility, commercialization requirements, operating model design, competitive dynamics, and long-term value creation potential.

This role bridges commercial strategy, commercialization planning, market access, pricing, business development assessment, portfolio evaluation, policy assessment, and integration planning to support informed investment decisions and long-term portfolio growth. In addition, this role supports Market Access policy initiatives and post‑acquisition integration planning by partnering with Market Access leadership, Business Development, and the central integration team to ensure successful evaluation, planning, and execution of new opportunities.

• Lead U.S. commercial assessments for acquisition, licensing, partnership and strategic business development opportunities.
• Evaluate strategic fit, unmet need, treatment paradigms, competitive intensity, market attractiveness and long‑term commercial potential.
• Support internal portfolio strategy initiatives including new indications, lifecycle management opportunities, reformulations and line extensions.
• Develop recommendations regarding commercial viability, launch feasibility, investment requirements, organizational implications and key risks.
• Assess alignment with corporate strategy and long‑term growth objectives.

• Lead commercial due diligence activities.
• Assess epidemiology, diagnosed populations, treated populations, addressable patient populations, treatment algorithms and site‑of‑care dynamics.
• Develop market sizing methodologies and opportunity assessments.
• Conduct primary and secondary research to validate assumptions.
• Partner with Business Analytics to validate epidemiology, patient opportunity and forecast inputs.
• Evaluate competitive landscapes, pipeline threats and future market evolution.
• Participate actively in diligence meetings with target companies and consultants.

• Develop pricing recommendations and commercial pricing frameworks.
• Evaluate pricing potential relative to clinical differentiation and payer expectations.
• Develop gross‑to‑net assumptions and reimbursement frameworks.
• Assess Medicare, Medicaid, Commercial, Specialty Pharmacy and Buy‑and‑Bill reimbursement implications.
• Evaluate payer management expectations, utilization management risks and access barriers.
• Assess coding, payment, contracting, distribution and channel considerations.

• Support assessment of evolving healthcare policy initiatives and their potential impact on commercial opportunity, pricing strategy, reimbursement, and long‑term asset value.
• Partner with Market Access leadership to evaluate policy developments related to GLOBE, GUARD, GENEROUS, MFN initiatives, and other pricing and reimbursement reform efforts.
• Support NPC‑related activities and monitor emerging policy developments and potential business implications.
• Develop analyses evaluating policy‑related risks and opportunities associated with acquisition, licensing, and portfolio opportunities.
• Support scenario planning exercises assessing policy impacts on pricing, reimbursement, access, contracting, and commercialization assumptions.
• Collaborate with Market Access subject matter experts to incorporate policy considerations into asset evaluations and strategic recommendations.

• Develop commercialization strategies and launch planning recommendations.
• Assess launch…